JPMorgan Healthcare Leaders ETF
JDOC
6 hedge funds and large institutions have $6.33M invested in JPMorgan Healthcare Leaders ETF in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
16% less capital invested
Capital invested by funds: $7.51M → $6.33M (-$1.17M)
21.7% less ownership
Funds ownership: 91.34% → 69.64% (-22%)
33% less funds holding
Funds holding: 9 → 6 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$731K |
| 2 |
IP
Ignite Planners
San Clemente,
California
|
-$529K |
| 3 |
BWAM
Blue Water Asset Management
Grand Rapids,
Michigan
|
-$228K |
| 4 |
LWP
LeClair Wealth Partners
Dublin,
Ohio
|
-$228K |
| 5 |
KF
Krilogy Financial
St. Louis,
Missouri
|
-$64.6K |
JDOC Hedge Fund Activity: Q2 2026 in Review
6 of the 8,340 institutional investors tracked by Wall St. Rank reported a position in JPMorgan Healthcare Leaders ETF (JDOC) for Q2 2026, worth a combined $6.33M — down 16% from $7.51M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of JDOC and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, cutting an estimated $731K.
- 6 institutional investors held JPMorgan Healthcare Leaders ETF (JDOC) as of Q2 2026, down from 9 in Q1 2026.
- Funds reported $6.33M of JPMorgan Healthcare Leaders ETF stock for Q2 2026, down 16% quarter-over-quarter.
- 0 funds opened new JPMorgan Healthcare Leaders ETF positions in Q2 2026 and 3 closed out, a net change of -3 holders.
- The largest JPMorgan Healthcare Leaders ETF seller in Q2 2026 was Citadel Advisors, an estimated $731K sold.
Based on aggregated 13F filings for Q2 2026.